Staska Pharmaceuticals, Inc. recalls Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Everg…
- Recall date
- September 30, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0040-2025
- FDA classification
- Class I
- Brand / firm
- Staska Pharmaceuticals, Inc.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Presence of Particulate Matter: Presence of glass particulates.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Get recall alerts
Free email alert whenever Staska Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Staska Pharmaceuticals, Inc.